Allen Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.73M Sell
10,760
-785
-7% -$183K 1.33% 15
2026
Q1
$2.82M Buy
11,545
+104
+0.9% +$24.2K 1.41% 13
2025
Q4
$2.37M Buy
11,441
+514
+5% +$102K 1.42% 16
2025
Q3
$2.03M Buy
10,927
+7,867
+257% +$1.35M 1.37% 16
2025
Q2
$467K Sell
3,060
-100
-3% -$15.4K 0.33% 40
2025
Q1
$524K Hold
3,160
0.36% 39
2024
Q4
$457K Sell
3,160
-407
-11% -$63.1K 0.33% 41
2024
Q3
$578K Buy
3,567
+100
+3% +$15.9K 0.4% 38
2024
Q2
$507K Sell
3,467
-21
-0.6% -$3.12K 0.45% 39
2024
Q1
$552K Buy
3,488
+14
+0.4% +$2.23K 0.49% 38
2023
Q4
$545K Buy
+3,474
New +$533K 0.53% 34

Other funds holding JNJ

Allen Wealth Management's JNJ Position: Q2 2026 in Review

Allen Wealth Management reduced its Johnson & Johnson (JNJ) stake by 6.8% in Q2 2026, selling an estimated $183K and leaving 10,760 shares worth $2.73M. The position accounts for 1.33% of the portfolio, ranked #15.

Allen Wealth Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.82M in Q1 2026. 2,267 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Allen Wealth Management held 10,760 shares of Johnson & Johnson worth $2.73M as of Q2 2026.
  • Allen Wealth Management sold 785 Johnson & Johnson shares in Q2 2026, an estimated $183K.
  • Johnson & Johnson made up 1.33% of Allen Wealth Management's portfolio in Q2 2026, its #15 holding.
  • Allen Wealth Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Allen Wealth Management's Johnson & Johnson position peaked at $2.82M in Q1 2026.
  • 2,267 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Allen Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.